Cargando…

Disease duration as an indicator of the efficacy of liraglutide in patients with type 2 diabetes mellitus

Comment on the article of Usui et al. Retrospective cohort study of obese patients with type 2 diabetes mellitus (n = 69) demonstrates that the glucose‐lowering effect of liraglutide as add on therapy to insulin relies on the remaining beta‐cell function in type 2 diabetes. Shorter disease duration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilbrink, Francis J, Mudde, Aart H, Mulder, Alexandra H, Bhansing, Kavish J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031510/ https://www.ncbi.nlm.nih.gov/pubmed/29974671 http://dx.doi.org/10.1111/jdi.12857

Ejemplares similares

Non-diabetic use of liraglutide
por: Verma, Abhyudaya
Publicado: (2012)

Monotherapy with liraglutide – Points to be focussed
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2019)

An accidental liraglutide overdose: case report
por: Elmehdawi, Rafik R., et al.
Publicado: (2014)

Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics
por: Jacobsen, Lisbeth V., et al.
Publicado: (2015)

Recent update on biological activities and pharmacological actions of liraglutide
por: Tiwari, Juhi, et al.
Publicado: (2017)

Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus
por: Okada, Kenta, et al.
Publicado: (2014)

Efficacy and safety of liraglutide in patients with type 2 diabetes mellitus and severe obstructive sleep apnea
por: Jiang, Wenlong, et al.
Publicado: (2022)

Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus
por: Mader, Julia K., et al.
Publicado: (2016)

Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes
por: Rodbard, H. W., et al.
Publicado: (2016)

Mehamudgaravati and type 2 diabetes mellitus
por: Wiwanitkit, Viroj
Publicado: (2011)

Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
por: Tian, Feng, et al.
Publicado: (2018)

Dietary Behaviors and Biochemical Serum Indicators in Adults with Type 2 Diabetes Mellitus from a Rural Region of Jalisco, Mexico
por: NAVARRO-MEZA, Monica, et al.
Publicado: (2018)

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
por: Neumiller, Joshua J, et al.
Publicado: (2010)

Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus
por: Albugami, Muneerah M., et al.
Publicado: (2020)

Analysis of the Influence of Type of Diabetes Mellitus on the Development and Type of Glaucoma
por: Zvornicanin, Jasmin
Publicado: (2015)

Myeloma and diabetes mellitus
por: Yasri, Sora, et al.
Publicado: (2014)

Karma and Diabetes Mellitus
por: Brož, Jan
Publicado: (2017)

Bladder dysfunction in women with type 2 diabetes mellitus
por: Tin, Sim Sai, et al.
Publicado: (2015)

Co-occurrence of Monilethrix and Type 1 Diabetes Mellitus
por: Vora, Rita V., et al.
Publicado: (2018)

Does disease duration influence the exercise training responses of patients with type 2 diabetes?
por: Park, Bong-Sup, et al.
Publicado: (2015)

Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
por: Bizino, Maurice B., et al.
Publicado: (2019)

Liraglutide in the treatment of type 2 diabetes mellitus: clinical utility and patient perspectives
por: Edavalath, Mahamood, et al.
Publicado: (2010)

Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide
por: Voukali, Maria, et al.
Publicado: (2014)

Effectiveness of Liraglutide in Type II Diabetes Mellitus Management: Experience in Emirati Patients
por: Ghuman, Nasrullah K, et al.
Publicado: (2015)

Retrospective Analysis of an Insulin-to-Liraglutide Switch in Patients with Type 2 Diabetes Mellitus
por: Bruinstroop, Eveline, et al.
Publicado: (2018)

Does a gluten-free diet determine the efficacy of sotagliflozin in patients with concomitant type 1 diabetes mellitus and celiac disease?
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2018)

Efficacy and Safety of a Biosimilar Liraglutide (Melitide(®)) Versus the Reference Liraglutide (Victoza(®)) in People with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Noninferiority Clinical Trial
por: Esteghamati, Alireza, et al.
Publicado: (2023)

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study
por: Nauck, Michael, et al.
Publicado: (2009)

The Effect of Clinically Indicated Liraglutide on Pericoronary Adipose Tissue in Type 2 Diabetic Patients
por: Biesenbach, Irmelin I. A., et al.
Publicado: (2023)

Successful lifestyle modifications may underlie umbilical cord-mesenchymal stromal cell effects in type 2 diabetes mellitus
por: Papadopoulou, Alexandra, et al.
Publicado: (2023)

Liraglutide for non-alcoholic fatty liver disease in children and adolescents: has a new era arrived?
por: Patoulias, Dimitrios Ioannis
Publicado: (2019)

Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials
por: Verma, Subodh, et al.
Publicado: (2019)

Therapeutic goal of diabetes mellitus
por: Wiwanitkit, Somsri, et al.
Publicado: (2011)

Prayer sign in diabetes mellitus
por: Upreti, Vimal, et al.
Publicado: (2013)

Herpes Zoster and Diabetes Mellitus
por: Chernev, Ivan, et al.
Publicado: (2014)

Foot care in diabetes mellitus
por: Vasudeva, Abhimanyu, et al.
Publicado: (2023)

Type 2 diabetes mellitus and ABO/Rh blood groups
por: Moinzadeh, Forouzan, et al.
Publicado: (2014)

Autoimmune Limbic Encephalitis Associated with Type 1 Diabetes Mellitus
por: Akın, Onur, et al.
Publicado: (2017)

Pontine Myelinolysis as the Presenting Complication of Type 2 Diabetes Mellitus
por: Ramineni, Kiran Kumar, et al.
Publicado: (2018)

Efficacy and Clinical Value of Liraglutide for Treatment of Diabetes Mellitus Complicated by Non-Alcoholic Fatty Liver Disease
por: Zhang, Zhongyong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u4l18ot04lrh95l9p0ogbg2hq3